Flu vaccine also linked to narcolepsy in adults, study reports

Finnish researchers unveiled new data Thursday to link the Pandemrix flu vaccine to a higher risk of the sleeping disorder narcolepsy in adults.

Other studies had already shown a link between the drug used in the 2009-10 "" outbreak and a higher incidence of narcolepsy in vaccinated children, teens and people under 30.

The new research, conducted by Finland's National Institute for Health and Welfare, found that Pandemrix-vaccinated adults between the ages of 20 and 64 had a three-to-five times higher risk of contracting the disease than non-vaccinated people.

Narcolepsy is a of the nervous system that causes excessive drowsiness, often causing people to fall asleep uncontrollably.

Pandemrix was the main vaccine used to fight the 2009-2010 outbreak of H1N1, which infected an estimated fifth of the world's population but turned out to be as dangerous as normal "seasonal" .

In Finland, 25 adults developed narcolepsy from 2009 to 2011—23 of them under 40 and none over 64, said the new study.

Eighteen had been given Pandemrix.

"The increased risk of narcolepsy attributed to vaccination with Pandemrix in adults was 1/100,000, whereas in children it was 6/100,000," the institute said in a statement.

The disorder normally occurs among 25-50 of every 100,000 people, although figures are sketchy, according to a recent British study.

In March, Swedish research linked the vaccine to a higher risk of narcolepsy among under-30's, not just children and teens as previously thought.

Sweden's Medical Products Agency found the risk was three times higher among under-20s given Pandemrix, and twice as high in those aged 21 to 30 years.

Neighbours Finland and Sweden recommended their populations of some five and 10 million people respectively, to take part in mass vaccinations during the swine flu scare.

Both governments have since agreed to provide for affected children.

Pandemrix, made by British drug company GlaxoSmithKline was the only used in both countries—it was given to about 60 percent of the Swedish population.

About 200 children under the age of 19 developed Narcolepsy in Sweden, and 80 in Finland.

But the institute said Pandemrix also prevented an estimated 80,000 swine flu infections in Finland and about 50 deaths.

In February, British research said Pandemrix boosted the narcolepsy risk among four-to-18-year-olds by a factor of 14.

Last September, the European Centre for Disease Prevention and Control (ECDC) said evidence from sleep centres in Finland and Sweden pointed to an added risk of one in 20,000 for Pandemrix-vaccinated children and teenagers.

add to favorites email to friend print save as pdf

Related Stories

Flu vaccine linked to narcolepsy in under 30s: study

Mar 26, 2013

A vaccine used in Sweden in the 2009-2010 "swine flu" pandemic is linked to a higher risk of the sleeping disorder narcolepsy among under 30s, and not just children and teens as previously thought, a Swedish study showed ...

Recommended for you

Mutating Ebola viruses not as scary as evolving ones

20 minutes ago

My social media accounts today are cluttered with stories about "mutating" Ebola viruses. The usually excellent ScienceAlert, for example, rather breathlessly informs us "The Ebola virus is mutating faster in humans than in animal hosts ...

War between bacteria and phages benefits humans

1 hour ago

In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages. In a new study, researchers from Tufts University, Massachusetts ...

Ebola kills 31 people in DR Congo: WHO

2 hours ago

An outbreak of the Ebola virus in the Democratic Republic of Congo has killed 31 people and the epidemic remains contained in a remote northwestern region, UN the World Health Organization (WHO) said Tuesday.

Dengue fever strikes models in Japan

5 hours ago

A worsening outbreak of dengue fever in Japan has claimed its first celebrities—two young models sent on assignment to the Tokyo park believed to be its source.

Japanese researchers develop 30-minute Ebola test

5 hours ago

Japanese researchers said Tuesday they had developed a new method to detect the presence of the Ebola virus in 30 minutes, with technology that could allow doctors to quickly diagnose infection.

Senegal monitors contacts of 1st Ebola patient

17 hours ago

Senegalese authorities on Monday were monitoring everyone who was in contact with a student infected with Ebola who crossed into the country, and who has lost three family members to the disease.

User comments